Holiday Authorization Notice from DHMH

Posted on by

To all our parents & nurses: per the DHMH guidelines, we cannot authorize nursing during the holidays listed below unless you have a work letter.

[pdf height=”125 em”]https://www.pnsnursing.com/wp-content/uploads/2016/11/Holiday-Auth-Notice.pdf[/pdf]

Notice Regarding Holiday Authorizations from DHMH

Posted on by

Dear Providers,

It has come to the DONS’ attention that renewal preauthorizations have been submitted to include holiday hours, specifically nursing services authorized for participants whose caregivers are employed.

Please note that verification must have been provided at the initial authorization noting that the caregiver (s) work schedule includes holidays. If not, the Program is unable to reimburse for these hours in accordance with COMAR 10.09.53 unless appropriate verification is submitted.

The Program will reimburse for awake and overnight nursing services, etc rendered on holidays. (This email specifically addresses nursing services authorized for the participant’s care in the absence of the participant’s working caregiver(s).)

If you have questions, please call or email me at your earliest convenience.

Thank you,

Dawnn Williams, Chief
Division of Nursing Services (DONS)
Department of Health and Mental Hygiene (DHMH)
201 West Preston Street, Rm 130
Baltimore, Maryland 21201
Tel: 410-767-1448

FDA: Medtronic Implements Worldwide Recall for Certain Lots of Neonatal and Pediatric Tracheostomy Tubes

Posted on by

FOR IMMEDIATE RELEASE – June 23, 2015 – Dublin, Ireland – Medtronic (NYSE: MDT) announced that on May 8, 2015, it began notifying hospitals and distributors worldwide that affected lots of its Covidien Shiley(TM) tracheostomy tubes were formed with a wider-angle bend than standard models manufactured after November 29, 2012.

The recall is limited to the product codes and associated lot numbers listed in the table below. If you are unable to determine the lot number of any of the product codes and size listed in the table, then those products should be treated as if they are within the affected lot numbers.

To read more, click here to continue to article from the FDA.